Skip to content
healthcare.dev

All Day Pain Relief

NDC 69517-109, Naproxen Sodium Tablets, 220 mg, tablet, from HealthLife of USA LLC.

Product NDC
69517-109
Status
Listed
Labeler
HealthLife of USA LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA091353
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69517-109 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
69517-109-02695170109022 POUCH in 1 POUCH (69517-109-02) / 2 TABLET in 1 POUCH
69517-109-0469517010904400 BOTTLE in 1 BOTTLE (69517-109-04) / 100 BOTTLE in 1 BOTTLE (69517-109-01) / 24 CARTON in 1 BOTTLE (69517-109-24) / 1 TABLET in 1 CARTON
69517-109-256951701092525 POUCH in 1 BOX (69517-109-25) / 2 TABLET in 1 POUCH
69517-109-506951701095050 POUCH in 1 BOX (69517-109-50) / 2 TABLET in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69517-109 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69517-109 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69517-109. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.